Matt Goddeeris, PhD, leverages his expertise as a cell biologist and drug hunter to drive therapeutic innovation. With over a decade of experience building teams around groundbreaking concepts, he has advanced three novel small molecules to IND across a range therapeutic areas to treat rare disease. Previous to Every Cure, Matt leverage AI/ML to fuel discovery at Cellarity and helped advance ELX-02 in cystic fibrosis and cystinosis clinical trials at Eloxx Pharmaceuticals. Matt earned his Bachelors of Science degree in Biochemistry at Michigan State University and PhD in Cell and Developmental Biology at Duke University.